Broker Ratings

The Cigna Group Share Price Target ‘$348.52’, now 16.5% Upside Potential

The Cigna Group with ticker code (CI) have now 21 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $385.00 and $287.00 calculating the average target price we see $348.52. Now with the previous closing price of $299.14 this is indicating there is a potential upside of 16.5%. The day 50 moving average is $291.62 and the 200 day moving average is $278.28. The total market capitalization for the company now stands at 87.61B. The stock price for the company is currently $299.40 USD

The potential market cap would be $102,072,559,473 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 16.9, revenue per share of $640.79 and a 3.55% return on assets.

The Cigna Group is a global health services company. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    The Cigna Group (CI) Stock Analysis: Exploring a 22.46% Potential Upside with Strong Buy Ratings

    The Cigna Group (NYSE: CI) is positioned as a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $79.88 billion, Cigna stands

    The Cigna Group (CI) Stock Analysis: Exploring a 21.49% Upside Potential for Investors

    The Cigna Group (NYSE: CI), a stalwart in the healthcare sector with a robust market cap of $80.27 billion, presents a compelling opportunity for investors seeking exposure to the healthcare

    The Cigna Group (CI) Investor Outlook: Assessing 17.94% Potential Upside and Strong Buy Ratings

    For investors navigating the dynamic landscape of healthcare stocks, The Cigna Group (NYSE: CI) stands out as a compelling opportunity. With a robust market capitalization of $83.01 billion and a

    Cigna Group (CI) Investor Outlook: 28.99% Upside Potential Makes This Healthcare Giant a Compelling Buy

    In the rapidly evolving landscape of the healthcare sector, The Cigna Group (NYSE: CI) stands out with its robust market presence and diversified product offerings. With a market capitalization of

    The Cigna Group (CI) Stock Analysis: Exploring a 28.99% Potential Upside for Healthcare Investors

    The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a robust market capitalization of $76.39 billion, Cigna continues

    The Cigna Group (CI) Stock Analysis: A 27% Upside Potential on the Horizon

    The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $77.51 billion, Cigna is a

      Search

      Search